|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/436 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1335725 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01996175.4 |
| Date of filing the European patent application | 2001-11-13 | |
| (97) | Date of publication of the European application | 2003-08-20 |
| (45) | Date of publication and mention of the grant of the patent | 2008-04-30 |
| (46) | Date of publication of the claims translation | 2008-08-25 |
| (86) | Number | PCT/US2001/047324 |
| Date | 2001-11-13 |
| (87) | Number | WO 2002/040000 |
| Date | 2002-05-23 |
| (30) | Number | Date | Country code |
| 249077 P | 2000-11-15 | US |
| (72) |
DUKART, Gary, US
GIBBONS, James, Joseph, Jr., US
SPEICHER, Lisa, Anne, US
FROST, Philip, US
DISCAFANI-MARRO, Carolyn, Mary, US
|
| (73) |
Wyeth,
Five Giralda Farms, Madison, NJ 07940-0874,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | CCI-779 panaudojimas antineoplastiniu agentu |
| USE OF CCI-779 AS AN ANTINEOPLASTIC AGENT |
| Payment date | Validity (years) | Amount | |
| 2009-10-05 | 9 | 720.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-11-13 |